• Kanamycin Sulfate: Water-Soluble Antibiotic for Microbiology

  2026-07-07

  Kanamycin Sulfate is a high-purity, water-soluble aminoglycoside antibiotic widely used in microbiology and antibiotic resistance research. Its mechanism centers on inhibiting bacterial protein synthesis, making it essential for cell culture selection and experimental workflows. This article details its properties, molecular action, benchmarks, and best practices for laboratory use.

• Oscillating mTORC1 Activity Regulates Cell Cycle Progression

  2026-07-07

  Joshi et al. reveal that mTORC1 activity dynamically oscillates throughout the cell cycle, peaking in S/G2 and reaching its nadir in mitosis and G1. These phase-specific fluctuations shape both mitotic entry and cellular sensitivity to autophagy, highlighting new regulatory links between cellular metabolism, checkpoint control, and proliferation.

• QX77: Advancing Chaperone-Mediated Autophagy in Translationa

  2026-07-06

  This thought-leadership article explores the mechanistic and strategic advantages of QX77 as a molecular chaperone activator for autophagy pathway modulation in translational research. Integrating recent mechanistic findings, experimental best practices, and differentiation from competing tools, it provides actionable guidance for researchers in autophagy and stem cell biology. The article contextualizes QX77 within the latest literature, including breakthroughs in mitophagy regulation, and outlines protocol parameters and future perspectives.

• DiscoveryProbe™ L1023: Precision Tools for Overcoming Cancer

  2026-07-06

  Explore how the DiscoveryProbe™ Anti-cancer Compound Library (L1023) advances high-throughput cancer research with a focus on resistance mechanisms and MCL1 inhibition. This article uniquely connects curated compound diversity to practical strategies for unraveling complex oncogenic signaling.

• Cathepsin B Inhibitor CA-074: Protocols & Troubleshooting Gu

  2026-07-05

  Cathepsin B inhibitor CA-074 enables selective and potent inhibition of cathepsin B activity in research workflows targeting cancer metastasis, neurotoxicity reduction, and immune modulation. This compound is best suited for experimental settings requiring high specificity and low off-target effects; it is not recommended for applications involving cathepsin H or L inhibition or for long-term solution storage.

• Actinomycin D: Applied Workflows for Transcriptional Inhibit

  2026-07-04

  Actinomycin D (ActD) remains an indispensable tool for dissecting transcriptional regulation, apoptosis induction, and mRNA stability in cancer research and stem cell differentiation. This article bridges recent findings with optimized protocols, troubleshooting, and strategic insights for leveraging ActD in high-impact experimental settings.

• MMP-2 Responsive Liposomes for Sequential Immunotherapy in B

  2026-07-03

  This study introduces an MMP-2 responsive dual-targeting liposome system for sequential delivery of a PD-1/PD-L1 blockade peptide and an IDO inhibitor, aiming to remodel the immunosuppressive microenvironment in breast cancer. The approach demonstrates enhanced specificity and immunotherapeutic efficacy, offering a promising paradigm for targeted nanomedicine-driven cancer immunotherapy.

• XAV-939: Applied Protocols for Wnt/β-Catenin Signaling Studi

  2026-07-03

  XAV-939 (NVP-XAV939) delivers nanomolar potency for precise modulation of Wnt/β-catenin signaling, making it a cornerstone in cancer, fibrosis, and bone formation research. This guide translates cutting-edge findings into actionable protocols and troubleshooting strategies, empowering scientists to maximize reproducibility and pathway insight with APExBIO’s trusted inhibitor.

• Moxidectin in Antifungal Research: Synergy and Protocol Inno

  2026-07-02

  Moxidectin, a macrocyclic lactone anthelmintic, is redefining experimental workflows by amplifying polyene antifungal efficacy against Candida albicans through ergosterol biosynthesis upregulation. This guide translates the latest research into actionable protocols, troubleshooting insights, and cross-domain opportunities for both veterinary and antifungal science.

• InstaBlue Protein Stain Solution: Rapid, Sensitive Protein V

  2026-07-02

  InstaBlue Protein Stain Solution by APExBIO streamlines protein electrophoresis analysis with ultra-fast, sensitive detection without hazardous solvents or time-consuming steps. Its unique workflow enables high-clarity visualization and mass spectrometry compatibility, making it ideal for advanced biomedical research and clinical antibody discovery.

• Mutational Landscape of Myeloma Cell Lines: Drivers, Pathway

  2026-07-01

  This study provides the first comprehensive exome-wide characterization of genomic mutations in a large cohort of human multiple myeloma cell lines (HMCLs). The findings illuminate key genetic drivers and pathways involved in tumor progression and drug resistance, offering a critical resource for selecting model systems and designing targeted research in hematological malignancy.

• Neticonazole Hydrochloride: Dual-Action Imidazole Antifungal

  2026-07-01

  Neticonazole Hydrochloride is an imidazole antifungal exhibiting both potent antifungal and antitumor activities. It inhibits fungal cell membrane synthesis and modulates exosome secretion and apoptosis pathways in colorectal cancer research. Its topical efficacy and dual mechanism position it as a key agent for superficial candidiasis and emerging oncology workflows.

• Weight Loss Restores Intestinal Stretch-Induced Satiety in O

  2026-06-30

  This study elucidates how obesity impairs, but weight loss restores, the ability of intestinal stretch to suppress food intake and improve glucose homeostasis. The findings reveal mechanistic independence from GLP-1 signaling and highlight the role of neural pathways, offering a new perspective for metabolic disease research.

• Cefepime (BMY-28142): Translational Leverage in CNS Infectio

  2026-06-30

  This thought-leadership article explores the mechanistic advantages and strategic use of Cefepime (BMY-28142) in translational CNS infection research. It bridges recent antimicrobial resistance findings, experimental optimization, and translational model design, while highlighting APExBIO's product for high-impact scientific workflows.

• Azithromycin: Analytical Quality, Impurity Control, and Assa

  2026-06-29

  Explore the advanced analytical strategies and impurity management that set Azithromycin apart as a macrolide antibiotic in bacterial infection research. This article uncovers how rigorous impurity quantification impacts experimental integrity, offering fresh scientific depth beyond standard application guides.

450 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page